Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ETHK LabsHKSE:01931 -1.69%74 OCF Margin % is 61.28% as of Dec. 2025, which is 896% above its 10-year median of 6.15. GuruFocus rates HKSE:01931 with a GF Score™ of 74/100 and a GF Value™ of HK$1.38 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 117 Medical Distribution companies, ETHK Labs ranks worse than 94.02% on this metric.
The historical rank and industry rank for ETHK Labs's OCF Margin % or its related term are showing as below:
HKSE:01931'
s OCF Margin % Range Over the Past 10 Years
Min: -32.58 Med: 6.15 Max: 14.61
Current: -32.03
During the past 10 years, the highest OCF Margin % of ETHK Labs was 14.61%. The lowest was -32.58%. And the median was 6.15%.
HKSE:01931's OCF Margin % is ranked worse than 94.02% of 117
companies
in the Medical Distribution industry
Industry Median: 1.99
vs HKSE:01931: -32.03
The historical data trend for ETHK Labs's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:01931 vs MCK, COR, CAH: OCF Margin % Comparison
For the Medical Distribution subindustry, ETHK Labs's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ETHK Labs OCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, ETHK Labs's OCF Margin % distribution charts can be found below:
* The bar in red indicates where ETHK Labs's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETHK Labs (HKSE:01931) has a OCF Margin % of 61.28% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ETHK Labs and its competitors. This is 896% above median its historical median of 6.15. According to the industry distribution chart, ETHK Labs ranks #110 out of 117 companies in the Medical Distribution industry, placing it in the top 94%.
Is ETHK Labs' OCF Margin % too high?
ETHK Labs' current OCF Margin % of 61.28% is 896% above median its 10-year median of 6.15. The Medical Distribution industry median OCF Margin % is 1.99. ETHK Labs' value of 61.28% is 2979.4% above this industry median. Based on the distribution chart, ETHK Labs ranks #110 out of 117 companies in the Medical Distribution industry, which is in the bottom quartile relative to peers. Overall, ETHK Labs has a GF Score™ of 74/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does ETHK Labs' OCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, ETHK Labs ranks #110 out of 117 companies for OCF Margin %. This places ETHK Labs in the lower half of its industry. The industry median OCF Margin % is 1.99. ETHK Labs' value of 61.28% is 2979.4% above this benchmark. While the company's 10-year median is 6.15 vs. the industry median of 1.99, ETHK Labs has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Distribution company?
The median OCF Margin % among Medical Distribution companies is 1.99, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ETHK Labs's current OCF Margin % of 61.28% is 2979.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on ETHK Labs and its competitors. For the Medical Distribution industry, the median OCF Margin % is 1.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ETHK Labs's current OCF Margin % is 61.28%, which is 896% above median its own 10-year median of 6.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ETHK Labs stock overvalued right now?
Based on GuruFocus' analysis, ETHK Labs (HKSE:01931) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.38, compared to a current price of HK$0.58 — trading 58% below its estimated fair value. The current OCF Margin % is 61.28%, which is 896% above median its 10-year median of 6.15 and 2979.4% above the Medical Distribution industry median of 1.99. ETHK Labs' overall GF Score™ is 74/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For ETHK Labs (HKSE:01931), the current OCF Margin % is 61.28% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ETHK Labs (HKSE:01931) Overvalued in 2026?
Based on GuruFocus' analysis, ETHK Labs stock appears to be undervalued.
The current stock price of HK$0.58 is trading 58% below its estimated GF Value™ of HK$1.38.
GuruFocus considers ETHK Labs to be Possible Value Trap.
Key valuation signals for HKSE:01931:
OCF Margin %: 61.28% (896% above median its 10-year median of 6.15)
GF Value™: HK$1.38 vs. price of HK$0.58 (58% below fair value)
Industry Position: 2979.4% above the Medical Distribution median (#110 of 117)
No single metric tells the full story. See the HKSE:01931 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ETHK Labs Inc is engaged in the distribution, after-sales service, and development of in-vitro diagnostic (IVD) products in China. The company operates through three business segments: Distribution Business, After-sales Services, and Self-branded Products Business. It distributes IVD analysers, reagents, and consumables to hospitals and healthcare institutions, provides maintenance and installation services for diagnostic equipment, and develops and sells self-branded IVD analysers and reagents. The company generates the majority of its revenue from Mainland China.
74GF Score
Get the complete analysis for HKSE:01931
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01931 has been successfully added to your 
